Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
There is no data on the use of Eversense® 365 during in pregnancy, for gestational diabetes or women that are nursing. There are currently no trials evaluating the safety and efficacy of Eversense® 365 in pregnancy, for gestational diabetes or for women that are nursing
Eversense® 365 CGM is not indicated for use in children.
Eversense® 365 is a continuous glucose monitoring system indicated for the management of diabetes in adults age 18 years and older.
Routine calibration is critically important to ensuring the best performance of the Eversense 365 CGM System. The following tips can help you improve your calibration measurements:
To order additional adhesives, check with your distributor that you ordered the Eversense® 365. You may be able to purchase additional white and clear Eversense® Adhesives.
The Eversense® 365 Adhesive Patch Kit includes:
- 300 White Adhesives
- 90 Clear Adhesives
Your smart transmitter communicates with both the sensor and the app to provide CGM information.
Your Eversense® 365 Smart Transmitter does the following:
- Powers the sensor.
- Calculates and stores glucose data.
- Provides on-body vibe alerts when the glucose alert level is reached.
- Sends glucose data to the app via Bluetooth®.
- Must be recharged using the charging cable.
- USB port on charging cable can be used to download data to compatible external applications.
- Multi-color LED to indicate various modes of the smart transmitter.
- Communicates with compatible mobile device.
- Can be powered ON or OFF.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1
Call My Eversense Specialist Now
Schedule a Call